Wells Fargo & Company Statera Biopharma, Inc. Transaction History

Wells Fargo & Company

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.08 - $0.23 $38 - $109	-475 Reduced 62.34%	287 $0
Q3 2022 Nov 14, 2022	BUY	$0.13 - $0.28 $63 - $137	491 Added 181.18%	762 $0
Q2 2022 Aug 12, 2022	BUY	$0.21 - $0.38 $20 - $37	98 Added 56.65%	271 $0
Q1 2022 May 16, 2022	BUY	$0.31 - $2.27 $7 - $56	25 Added 16.89%	173 $0
Q4 2021 Feb 14, 2022	SELL	$2.01 - $4.08 $16 - $32	-8 Reduced 5.13%	148 $0
Q3 2021 Nov 15, 2021	BUY	$2.29 - $6.24 $357 - $973	156 New	156 $0

30K

Ticker STAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,295,700
Description
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.